FIRST TRUST ADVISORS LP

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1125816 Wheaton, IL

Position in MDGL

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$10,645,570

-$992,738 QoQ

Shares Held

19,826

-10.8% QoQ

Ownership

0.086%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#89

of 411 holders

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $2,824,813,122 across 97 Biotechnology names. MDGL ranks #38 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	547,132	$341,158,687
2	INCY	Incyte Corp	1,587,996	$180,015,226
3	CORT	Corcept Therapeutics Inc	1,829,545	$159,078,937
4	VRTX	Vertex Pharmaceuticals Inc / Ma	289,179	$143,643,884
5	EXEL	Exelixis, Inc.	2,543,353	$138,383,836
6	ALNY	Alnylam Pharmaceuticals, Inc.	421,534	$126,894,380
7	KRYS	Krystal Biotech, Inc.	324,900	$120,755,583
8	AXSM	Axsome Therapeutics, Inc.	482,061	$117,994,070

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,645,570	19,826	-10.8%	Shares	Sole	2026-08-11
2026-03-31	$11,638,308	22,233	-10.4%	Shares	Sole	2026-05-13
2025-12-31	$14,453,096	24,819	+554.0%	Shares	Sole	2026-02-13
2025-09-30	$1,740,614	3,795	+117.4%	Shares	Sole	2025-11-12
2025-06-30	$528,409	1,746	-63.7%	Shares	Sole	2025-08-13
2025-03-31	$1,592,553	4,808	+19.8%	Shares	Sole	2025-05-14
2024-12-31	$1,238,599	4,014	+50.8%	Shares	Sole	2025-02-13
2024-09-30	$564,929	2,662	-19.0%	Shares	Sole	2024-11-13
2020-12-31	$365,304	3,286	+58.5%	Shares	Sole	2021-02-02
2020-09-30	$246,127	2,073	—	Shares	Sole	2020-11-05
No filing history on record for this holder in this stock.